Zinbryta Lawsuit
Worldwide Zinbryta recall issued amid reports of brain inflammation and wrongful deaths.
Topic Archives: Zinbryta
-
-
Zinbryta Brain Inflammation Risks Outweigh Benefits: EMA
European regulators say they have positively confirmed that the recently recalled MS drug Zinbryta had health risks that outweighed any potential benefits, indicating that causes of severe brain inflammation were…
-
Zinbryta Risks Prevented Use As MS Drug, Despite Effectiveness of Treatment: Report
A new study indicates that Zinbryta side effects were so severe it could have never become a major drug product, raising questions as to why it was approved when there…
-
Zinbryta Withdrawal from U.S. Market to Be Complete April 30
The FDA says it will help multiple sclerosis patients transition to other drugs following a Zinbryta recall, and will let it stay on the market until the end of April.
-
Zinbryta Recall Recommended by European Regulators, Following Reports Of Encephalitis, Patient Deaths
A Zinbryta recall and ban has been recommended in the EU following a dozen reports of serious brain inflammation linked to at least three patient deaths.
